Limiting Dexamethasone Exposure With Highly Emetogenic Chemotherapy Regimens: Is the Verdict In?

Hesketh PJ

Open source

DOI
10.1200/jco-26-01492
Published
2026 Sep
Container
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-01492,
  title = {Limiting Dexamethasone Exposure With Highly Emetogenic Chemotherapy Regimens: Is the Verdict In?},
  author = {Hesketh PJ},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-26-01492},
  url = {https://doi.org/10.1200/jco-26-01492}
}

RIS

TY  - JOUR
TI  - Limiting Dexamethasone Exposure With Highly Emetogenic Chemotherapy Regimens: Is the Verdict In?
AU  - Hesketh PJ
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-26-01492
UR  - https://doi.org/10.1200/jco-26-01492
ER  - 

APA

PJ, H. (2026). Limiting Dexamethasone Exposure With Highly Emetogenic Chemotherapy Regimens: Is the Verdict In?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-26-01492

Source records